Noubar Afeyan, Director at Moderna, Inc. (MRNA), sold 10,000 shares at $75.30 ($760K) on 2023-11-01, disclosed to the SEC on 2023-11-03.
Scheduled sale ($760k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.30 | 1,900 | $143K | 18.8% |
| 2 | $76.17 | 8,100 | $617K | 81.2% |
| Total | $76.00 avg | 10,000 | $760K | 100% |
| Filing → |
| MRNA | SELL | 2025-12-15 | $1.4M | — | Filing → |
| MRNA | SELL | 2024-08-02 | $3.6M | — | Filing → |
| MRNA | SELL | 2024-07-26 | $2.9M | — | Filing → |